Association of Longitudinal Changes in Cerebral Microstructure with Cognitive Functioning in Breast Cancer Survivors after Adjuvant Chemotherapy

被引:1
|
作者
Chen, Vincent Chin-Hung [1 ,2 ]
Wu, Yi-Fang [3 ]
Tsai, Yuan-Hsiung [1 ,4 ]
Weng, Jun-Cheng [2 ,3 ,5 ]
机构
[1] Chang Gung Univ, Sch Med, Taoyuan 333, Taiwan
[2] Chang Gung Mem Hosp, Dept Psychiat, Chiayi 613, Taiwan
[3] Chang Gung Univ, Dept Med Imaging & Radiol Sci, 259,Wenhua 1st Rd, Taoyuan 333, Taiwan
[4] Chang Gung Mem Hosp, Dept Diagnost Radiol, Chiayi 613, Taiwan
[5] Chang Gung Univ, Dept Artificial Intelligence, Taoyuan 333, Taiwan
关键词
breast cancer; chemotherapy; cognitive impairment; voxel-based morphometry (VBM); vertex-based shape analysis; WHITE-MATTER; CAUDATE-NUCLEUS; GRAY-MATTER; MECHANISMS; WOMEN; IMPAIRMENT; THERAPY; MEMORY; MRI;
D O I
10.3390/jcm13030668
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Adjuvant chemotherapy for breast cancer might impact cognitive function and brain structure. Methods: In this study, we investigated the cerebral microstructural changes in breast cancer survivors after adjuvant chemotherapy and the correlation with cognitive function with both cross-sectional and longitudinal study designs. All participants underwent structural MRI. In total, we recruited 67 prechemotherapy patients (BB), 67 postchemotherapy patients (BA), and 77 healthy controls (BH). For the follow-up study, 28 participants in the BH and 28 in the BB groups returned for imaging and assessment (BHF, BBF). Voxel-based morphometry analysis was performed to evaluate differences in brain volume; vertex-based shape analysis was used to assess the shape alterations of subcortical regions. Moreover, multiple regression was applied to assess the association between the changes in neuropsychological assessment and brain volume. Results: The results showed brain volume reduction in the temporal and parietal gyrus in BB and BA patients. Among each group, we also found significant shape alterations in the caudate and thalamus. Volume reductions in the temporal regions and shape changes in the caudate and hippocampus were also observed in patients from time point 1 to time point 2 (postchemotherapy). An association between brain volume and cognitive performance was also found in the limbic system. Conclusions: Based on our findings, we can provide a better understanding of the cerebral structural changes in breast cancer survivors, establish a subsequent prediction model, and serve as a reference for subsequent treatment.
引用
收藏
页数:18
相关论文
共 50 条
  • [41] Longitudinal patterns of postdiagnosis weight changes according to adjuvant systemic treatments in Korean breast cancer survivors
    Lee, J. W.
    Min, Y. H.
    Chung, I. Y.
    Ahn, S. H.
    BREAST, 2017, 32 : S24 - S24
  • [42] A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients
    Jansen, Catherine E.
    Cooper, Bruce A.
    Dodd, Marylin J.
    Miaskowski, Christine A.
    SUPPORTIVE CARE IN CANCER, 2011, 19 (10) : 1647 - 1656
  • [43] A prospective longitudinal study of chemotherapy-induced cognitive changes in breast cancer patients
    Catherine E. Jansen
    Bruce A. Cooper
    Marylin J. Dodd
    Christine A. Miaskowski
    Supportive Care in Cancer, 2011, 19 : 1647 - 1656
  • [44] Interaction between APOE Ɛ4 status, chemotherapy and endocrine therapy on cognitive functioning among breast cancer survivors: the CANTO-Cog longitudinal study
    Mylène Duivon
    François Christy
    Emilie Thomas
    Justine Lequesne
    Hélène Castel
    Catherine Gaudin
    Dominique Delmas
    Sandrine Boyault
    Olivier Rigal
    Chayma Bousrih
    Christelle Lévy
    Florence Lerebours
    Antonio Di Meglio
    Patricia A. Ganz
    Kathleen Van Dyk
    Ines Vaz Luis
    Marie Lange
    Florence Joly
    Breast Cancer Research, 27 (1)
  • [45] Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma
    Schagen, SB
    van Dam, FSAM
    Muller, MJ
    Boogerd, W
    Lindeboom, J
    Bruning, PF
    CANCER, 1999, 85 (03) : 640 - 650
  • [46] Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen
    Castellon, SA
    Ganz, PA
    Bower, JE
    Petersen, L
    Abraham, L
    Greendale, GA
    JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 2004, 26 (07) : 955 - 969
  • [47] ERP amplitude and latency in breast cancer survivors treated with adjuvant chemotherapy
    Kreukels, Baudewijntje P. C.
    Hamburger, Hans L.
    de Rulter, Michiel B.
    van Dam, Frits S. A. M.
    Ridderinkhof, K. Richard
    Boogerd, Willem
    Schagen, Sanne B.
    CLINICAL NEUROPHYSIOLOGY, 2008, 119 (03) : 533 - 541
  • [48] Chemotherapy, neurotoxicity, and cognitive changes in breast cancer
    Dutta, Varsha
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2011, 7 (03) : 264 - 269
  • [49] Nutritional approaches to late toxicities of adjuvant chemotherapy in breast cancer survivors
    Rock, E
    DeMichele, A
    JOURNAL OF NUTRITION, 2003, 133 (11): : 3785S - 3793S
  • [50] Longitudinal assessment of cognitive changes associated with adjuvant treatment for breast cancer: the impact of APOE and smoking
    Ahles, Tim A.
    Li, Yuelin
    McDonald, Brenna C.
    Schwartz, Gary N.
    Kaufman, Peter A.
    Tsongalis, Gregory J.
    Moore, Jason H.
    Saykin, Andrew J.
    PSYCHO-ONCOLOGY, 2014, 23 (12) : 1382 - 1390